Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression.
about
Fasting for haemostasis in children with gastrointestinal bleedingFasting for haemostasis in children with gastrointestinal bleedingScience review: The use of proton pump inhibitors for gastric acid suppression in critical illnessA review of stress-related mucosal diseaseDynamic functional and ultrastructural changes of gastric parietal cells induced by water immersion-restraint stress in rats.The oral cavity and age: a site of chronic inflammation?Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study.Association between acute pancreatitis and peptic ulcer disease.The comparison of extemporaneous preparations of omeprazole, pantoprazole oral suspension and intravenous pantoprazole on the gastric pH of critically ill-patients.Gastric mucosal injury due to hemorrhagic reperfusion and efficacy of Salvia miltiorrhizae extract F and cimetidineStress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers?Association between illness severity and timing of initial enteral feeding in critically ill patients: a retrospective observational study.When to feed the patient with gastrointestinal bleeding.Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy menAcute esophageal necrosis and low-flow stateStress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trialGastrointestinal prophylaxis in neurocritical care.Stress prophylaxis in intensive care unit patients and the role of enteral nutrition.Safety of enteral feeding in patients with open abdomen, upper gastrointestinal bleed, and perforation peritonitis.Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.Stress-related mucosal disease in the critically ill patient.Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.Prevalence and risk factors for development of hemorrhagic gastro-intestinal disease in veterinary intensive care units in the United Kingdom.Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress.Stress Ulcer Prophylaxis in Neurocritical Care.Effect of sucralfate on gastric permeability in an ex vivo model of stress-related mucosal disease in dogs.The natural history of perforated foregut ulcers after repair by omental patching or primary closure.Profilaxia das úlceras associadas ao estresse
P2860
Q24185757-AE7405E9-D3EF-417A-BE63-7F3429AF91D0Q24200781-E0D91BC8-4A63-4C92-A150-8D9CC4F7BF2AQ24802292-37F5D2F0-6298-49E7-A8F8-E10AB7FC667FQ28259245-DB634D13-C9B7-4088-BF05-794F1C44157BQ33245098-00F3A466-8552-43CF-A3D7-65D27F458750Q33312367-89924A20-8F2E-4F04-9767-6BA70CFF2202Q34368219-0552AB60-BFA1-4A36-984D-3684F6A33E03Q34670887-7C0B21CC-E58D-40C4-832C-BEBB54A0DFE6Q34975573-268A5FB0-20DD-4BAC-BEA7-7EFE765AE750Q35011306-53F1C647-6DD3-4816-8C6D-E3F0FCCFD52CQ35172918-EE4EDECE-A105-4B5C-8790-8D7256808D1CQ36217851-34368537-BDB3-4E82-93CF-EF4795DFD3FDQ36278469-418CE084-E9FF-44A3-96E3-11DDB3F29DB7Q36489989-2896330E-E76F-4A90-B7F6-FA21BB7C4E07Q36790578-B7F03954-EAB3-4E96-9F9F-73EC33E856B6Q36815246-183C8600-339E-47AF-A257-EF00E73C7DF9Q37900222-5088839E-4DF3-4DE0-BEC9-2E29BB873A3DQ37993057-F1069720-F66A-4A6A-98B9-D248843C711BQ38018502-D68BBFFD-132B-4E5E-B373-299C37102C0EQ38025609-2E9D0A0F-045A-4FD7-8BC7-F0ECCA28A8F0Q38308249-C1E6B208-5602-46BA-8354-0084ED9A692CQ41064092-48C34382-E2BF-4752-B9BF-AE7CD93A42A9Q41070710-F9A96534-FFB5-41A1-8E21-A44EE4FFBA3AQ47788629-9E223BC8-51E8-480E-BC2B-387E7079BEEAQ47956386-6EA2A6DF-AF7B-4FB1-B007-7C22BA9D7988Q49822200-B4C91E8B-C70D-41AB-886E-5DA575452D26Q50516738-0C389B3D-6DAE-4E19-BC0A-19122951EC87Q58861130-62FEF708-BAC6-4285-99ED-AEE05CECE7F2
P2860
Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pathophysiology of the upper g ...... benefits of acid suppression.
@ast
Pathophysiology of the upper g ...... benefits of acid suppression.
@en
Pathophysiology of the upper g ...... benefits of acid suppression.
@nl
type
label
Pathophysiology of the upper g ...... benefits of acid suppression.
@ast
Pathophysiology of the upper g ...... benefits of acid suppression.
@en
Pathophysiology of the upper g ...... benefits of acid suppression.
@nl
prefLabel
Pathophysiology of the upper g ...... benefits of acid suppression.
@ast
Pathophysiology of the upper g ...... benefits of acid suppression.
@en
Pathophysiology of the upper g ...... benefits of acid suppression.
@nl
P1476
Pathophysiology of the upper g ...... benefits of acid suppression.
@en
P2093
M Brian Fennerty
P304
P356
10.1097/00003246-200206001-00002
P407
P433
P577
2002-06-01T00:00:00Z